Skip to content

Screening and efficacy evaluation of plasma biomarkers for predicting postoperative acute kidney injury in elderly patients

Screening and efficacy evaluation of plasma biomarkers for predicting postoperative acute kidney injury in elderly patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056702
Enrollment
Unknown
Registered
2022-02-10
Start date
2022-02-10
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute kidney injury

Interventions

None listed

Sponsors

Affiliated Hospital of Weifang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Surgical patients scheduled for surgical treatment.

Exclusion criteria

Exclusion criteria: 1. End-stage renal disease; 2. A history of chronic dialysis or acute dialysis before entering the room; 3. AKI before surgery; 4. Do not agree to be included in the group or data is missing; 5. A history of nephrectomy; 6. A history of kidney transplantation.

Design outcomes

Primary

MeasureTime frame
Proteomic analysis;

Countries

China

Contacts

Public ContactYang Xiying

Affiliated Hospital of Weifang Medical University

yangxy0028@163.com+86 13455666228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026